Tulip Infratech to Build ₹1,100 Crore Luxury Housing Project in Gurugram
Source: Economictimes
Arth Insight · What this means for your wallet
- If you own property in Gurugram, especially near the Southern Peripheral Road, its value may appreciate due to increased developer confidence and luxury demand.
- If you're considering buying a home in Gurugram, expect more high-end choices, but also potentially higher premium pricing in key development areas.
- The ₹1,100 crore investment can boost local job creation and economic activity in Gurugram's construction and service sectors, indirectly benefiting the local economy.
Tulip Infratech has announced a massive ₹1,100 crore investment to develop a new luxury residential project called Tulip Melrose in Gurugram. Located on the Southern Peripheral Road, the project will feature over 600 premium units and is scheduled for completion within four years.
- ▸Tulip Infratech is investing ₹1,100 crore in a new luxury project named Tulip Melrose in Gurugram.
- ▸The project will be located on the Southern Peripheral Road (SPR), a key growth corridor for the city.
- ▸More than 600 luxury homes are planned, with a completion target of four years.
- ✓Tulip Infratech is investing ₹1,100 crore in a new luxury project named Tulip Melrose in Gurugram.
- ✓The project will be located on the Southern Peripheral Road (SPR), a key growth corridor for the city.
- ✓More than 600 luxury homes are planned, with a completion target of four years.
Real estate developer Tulip Infratech is set to significantly increase its footprint in the National Capital Region (NCR) with the announcement of a new high-end residential project. The company has committed a substantial investment of ₹1,100 crore to develop 'Tulip Melrose,' an upscale housing venture located in one of Gurugram's most rapidly developing corridors.
Strategic Location on Southern Peripheral Road
The new project will be situated along the Southern Peripheral Road (SPR), a location that has emerged as a major hub for luxury real estate in recent years. The SPR is highly valued by investors and homebuyers due to its strategic connectivity to the Golf Course Extension Road, Sohna Road, and the Dwarka Expressway. By choosing this location for a ₹1,100 crore investment, Tulip Infratech is positioning itself to capture the growing demand for premium living spaces in this specific pocket of Gurugram.
Project Scale and Features
Tulip Melrose is designed to cater to the luxury segment, reflecting the broader market trend where buyers are increasingly seeking larger, well-appointed homes with modern amenities. Key details of the development include:
- Unit Count: The project will offer more than 600 exquisite residential units.
- Investment: A total outlay of ₹1,100 crore has been earmarked for construction and development.
- Timeline: The developer expects to complete the project over the next four years.
Market Implications for Retail Investors
This investment signals a strong vote of confidence in the Gurugram property market, particularly the luxury segment. For retail investors and potential homeowners, such a large-scale commitment by a developer suggests expectations of sustained demand and potential capital appreciation in the area. Massive residential projects of this nature often act as catalysts for local infrastructure growth, potentially leading to better civic amenities and commercial development in the vicinity of the Southern Peripheral Road.
As the construction unfolds over the next 48 months, the project is expected to contribute to the evolving skyline of Gurugram, which continues to be a preferred destination for high-net-worth individuals and corporate professionals seeking premium residential options near major business districts.
Real estate investments are subject to market risks; readers should conduct their own due diligence as property values and capital appreciation are not guaranteed.
Loan interest rates, processing fees and eligibility are set by the lender and subject to credit approval — verify current terms before applying. Some listings may be sponsored. Not financial advice.
Frequently Asked Questions
Where exactly in Gurugram is the Tulip Melrose project located?
The project is located along the Southern Peripheral Road (SPR), which is a major arterial road connecting several key residential and commercial hubs in Gurugram.
How many houses will be available in this new development?
Tulip Melrose will feature over 600 exquisite residential units catering to the luxury housing segment.
What is the expected timeline for the completion of the project?
The developer, Tulip Infratech, plans to complete the construction of the project over the next four years.
Join the Arth Vani channels
Daily news summaries, IPO & market alerts on Telegram and WhatsApp.
Because you read about real-estate
BreakingPiramal Pharma Slashes China Reliance to Under 10% for Supply Chain Resilience
Piramal Pharma has significantly reduced its dependence on Chinese raw materials to less than 10%. This strategic move aims to enhance supply chain resilience against geopolitical risks, with the company expanding its manufacturing footprint to India, the UK, and the US.
Dr Reddy's Pivots to Generic Semaglutide, Biosimilars for Future Growth
Dr Reddy's Laboratories is strategically focusing on the relaunch of generic semaglutide and expanding its biosimilars portfolio to drive future growth. This comes as the company navigates mixed results, with domestic formulations business growing but North American Revlimid sales declining in the September quarter.
Aayush Wellness Launches Calcium & Vitamin D Tablets, Enters ₹1.35 Lakh Crore Bone Health Market
Aayush Wellness Limited has launched new calcium and vitamin D tablets, marking its entry into India's significant bone and joint health segment. This expansion reflects the growing consumer demand for preventive healthcare and nutritional supplements designed to support musculoskeletal health.
Related Stories
BreakingPiramal Pharma Slashes China Reliance to Under 10% for Supply Chain Resilience
Piramal Pharma has significantly reduced its dependence on Chinese raw materials to less than 10%. This strategic move aims to enhance supply chain resilience against geopolitical risks, with the company expanding its manufacturing footprint to India, the UK, and the US.
Dr Reddy's Pivots to Generic Semaglutide, Biosimilars for Future Growth
Dr Reddy's Laboratories is strategically focusing on the relaunch of generic semaglutide and expanding its biosimilars portfolio to drive future growth. This comes as the company navigates mixed results, with domestic formulations business growing but North American Revlimid sales declining in the September quarter.
Aayush Wellness Launches Calcium & Vitamin D Tablets, Enters ₹1.35 Lakh Crore Bone Health Market
Aayush Wellness Limited has launched new calcium and vitamin D tablets, marking its entry into India's significant bone and joint health segment. This expansion reflects the growing consumer demand for preventive healthcare and nutritional supplements designed to support musculoskeletal health.
NITI Aayog Eyes Policy Reforms to Boost India's Medical Device Manufacturing
NITI Aayog is actively exploring new policy measures to enhance India's domestic manufacturing capabilities for medical and dental devices. The initiative addresses significant hurdles like complex regulations and cost disadvantages faced by local producers. The goal is to strengthen the 'Make in India' drive within the crucial healthcare sector.